MedTrace Logo

Non Interventional Study to Evaluate the Efficacy and Tolerability of Ectoin Containing Ophthalmic Solution

NCT01684852 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 64

Last updated 2026-01-29

No results posted yet for this study

Summary

This is a comparative, open label, parallel group, non interventional study to further demonstrate the efficacy and tolerability of BAT04. In addition the efficacy and safety shall be compared to Hyaluronic acid (HA)-Product. The patient applies BAT04 or HA-Product according to the instructions for use six times daily in both eyes over a period of 28 days. Response to treatment is recorded at day 28.

Conditions

  • Dry Eye Syndromes

Interventions

OTHER

Medical device, drug-like

Sponsors & Collaborators

  • Bitop AG

    lead INDUSTRY

Principal Investigators

  • Elisabeth Messmer, MD · Augenklinik der LMU Klinikum der Universität München

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-05-31
Primary Completion
2012-11-30
Completion
2012-11-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01684852 on ClinicalTrials.gov